Get involvedDonate today
Donate today
Donate today
March 19, 2019, 1:00pm – 2:00pm EDT

Nephrotic syndrome and FSGS

Nephrotic syndrome is a group of symptoms that, together, indicate your kidneys are not working as well as they should; and FSGS is the leading kidney disease that causes nephrotic syndrome.

Protein in urine is a defining symptom of both nephrotic syndrome and FSGS. Learn more about these two kidney conditions to better understand your risk and the treatment options available.

man with doctor

Dr. Kirk Campbell, an expert on nephrotic syndrome, will explain how nephrotic syndrome and FSGS are related, current treatment options and the potential benefits of enrolling in clinical trials.

Join this webinar to learn more about:

  • What nephrotic syndrome is
  • The causes of nephrotic syndrome
  • FSGS and available treatments
  • The potential benefits of enrolling in clinical trials

This webinar is supported by

Documents

Speaker

kirk-campbell-md

Kirk Campbell, MD

Dr. Kirk Campbell is an Associate Professor of Medicine, Vice Chair for Diversity and Inclusion and Director of the Nephrology Fellowship Program at the Icahn School of Medicine at Mount Sinai. He received his medical degree from the University of Connecticut and completed a residency in internal medicine at Yale-New Haven Hospital in New Haven, CT. He then completed a clinical and research fellowship in Nephrology at the Mount Sinai Medical Center.

In addition to treating patients with renal disease, Dr. Campbell leads an NIH-funded research program focused on understanding the mechanism of podocyte injury in the progression of proteinuric kidney diseases. He actively participates in clinical trials testing novel agents for primary glomerular disease.

Dr. Campbell is a prior Nephcure Foundation Young Investigator Awardee and a recipient of the Carl Gottschalk Research Grant from the American Society of Nephrology. He has previously served as a Clinical Attending at Yale-New Haven Hospital and on faculty at the University of Miami Miller School of Medicine. He is the Vice President of the New York Society of Nephrology, a standing member of the Pathobiology of Kidney Disease (PBKD) study section at the National Institutes of Health and a member of the Medical Advisory Board of the National Kidney Foundation of Greater New York.